Marché spécifique des allergies au pollen au Mexique, par type de médicament ( antihistaminiques , décongestionnants, corticostéroïdes, anticholinergiques et autres), test de diagnostic (test in vivo et test in vitro), produit (instruments, réactifs et kits, et autres), utilisateur final (hôpitaux, laboratoires de diagnostic, instituts universitaires et de recherche, et autres), canal de distribution (appels d'offres directs et ventes au détail) - Tendances et prévisions de l'industrie jusqu'en 2029.
Analyse et perspectives du marché des allergies au pollen spécifiques au Mexique
Le marché mexicain des allergies au pollen est stimulé par des facteurs tels que la forte prévalence de la réponse allergique au pollen , l'approbation croissante de nouveaux médicaments au Mexique avec différentes thérapies avancées pour lutter contre les allergies, entre autres, qui stimulent la croissance du marché. Les aéroallergènes polliniques peuvent constituer une opportunité pour le marché et propulser le marché au Mexique. L'impact sur la population pédiatrique dépend des conditions environnementales, des changements dans l'utilisation du sol, des différentes saisons polliniques et des données annuelles des allergologues en termes de planification du traitement. Actuellement, l'augmentation des dépenses de santé et la croissance du marché pharmaceutique devraient également propulser la croissance du marché. La prévalence des maladies allergiques augmente, ce qui nécessite une méthode intégrée de diagnostic, de traitement et une plus grande sensibilisation des patients. Une vaste population souffre de maladies allergiques qui ont généré un fardeau important. L'augmentation des cas d'allergies devrait augmenter la demande de traitement, entraînant une forte croissance du marché au cours de la période de prévision.
Le marché mexicain des allergies spécifiques au pollen devrait croître au cours de la période de prévision en raison de l'augmentation du nombre d'acteurs sur le marché et de la présence de nouveaux médicaments. Parallèlement à cela, les fabricants sont engagés dans des activités de R&D pour lancer de nouveaux produits sur le marché. L'augmentation du nombre de programmes de recherche et développement et l'augmentation des partenariats public-privé pour faciliter les nouveaux développements pour un traitement innovant et efficace influencent davantage le marché. Cependant, les effets indésirables des médicaments utilisés sur le marché et l'utilisation abusive de médicaments stéroïdiens devraient freiner la croissance du marché au cours de la période de prévision. Cependant, le coût élevé du traitement empêche les patients de s'adapter à des solutions de haute qualité et efficaces. Désormais, le coût élevé des procédures de traitement a un impact négatif sur le coût du traitement global. De plus, les médicaments actuellement disponibles
Mexico specific pollen allergies market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for safe distribution of machine and drugs products are the major drivers which propelled the demand of the market in the forecast period.
Mexico specific pollen allergies market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Mexico specific pollen allergies market will grow at a CAGR of 6.5% during the forecast period of 2022 to 2029.
Report Metric |
Details |
Forecast Period |
2022 to 2029 |
Base Year |
2021 |
Historic Years |
2020 (Customizable to 2019-2014) |
Quantitative Units |
Revenue in USD Million, Pricing in USD |
Segments Covered |
By Drug Type (Antihistamines, Decongestants, Corticosteroids, Anticholinergics and Others), Diagnostic Test (In Vivo Test and In Vitro Test), Product (Instruments, Reagents and Kits and Others), End User (Hospitals, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales) |
Countries Covered |
Mexico |
Market Players Covered |
Siemens Healthcare GmbH, Sanofi, bioMérieux SA, GlaxoSmithKline plc., Minaris Medical America, Inc., Quest Diagnostics Incorporated, Circassia, Alcon Inc., Thermo Fisher Scientific Inc, Johnson & Johnson SA de CV, Lincoln Diagnostics, Inc, EUROIMMUN Medizinische Labordiagnostika AG, Bayer Pharmaceuticals, Prestige Consumer Healthcare Inc., CINFA LABORATORIES, Perrigo Company plc., among others. |
Market Definition
Allergic diseases are the immunological response of the body to a particulate matter when it invades the body. These include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, a runny nose, shortness of breath, or swelling. These pollens (typically weed pollens) are easily found in the atmosphere in the spring season as well as grass pollens in the summer. Most of the pollen that causes allergic reactions comes from trees, grasses, and weeds. These plants make small, light, and dry pollen grains that travel by air. These are easily found everywhere. Since, it is difficult to completely avoid allergens and therefore, it is crucial to accurately identify the causative antigen for rapid diagnosis and prompt initiation of treatment of allergen immunotherapy. Pollen counts are generally taken with an air-sampling device.
The prevalence of allergic diseases is increasing, which requires an integrated method for diagnosis, treatment and greater awareness among patients. A vast population is suffering from allergic diseases that have generated a significant burden. Rising cases of allergies are expected to increase the demand for treatment, leading to the high growth of the market over the forecast period.
Mexico Specific Pollen Allergies Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of these are discussed in detail below:
Drivers
- Increasing prevalence of allergic disorder
The hypersensitive response of the immune system of an allergic individual to a substance is known as allergic reaction. When an allergen enters the body, it causes the body's immune system to develop an allergic reaction. This reaction can occur when the immune system attacks a normally harmless substance. This can happen in any age, but more frequent in younger age due to the proper functioning of immune response.
Different individuals can be allergic to various allergens, such as pollens allergies among others, which are some of the common allergic reactions. The prevalence of allergic diseases is increasing, which requires an integrated method for diagnosis, treatment and greater awareness among patients. A vast population is suffering from allergic diseases that have generated a significant burden. Rising cases of allergies are expected to increase the demand for treatment, leading to the high growth of the market over the forecast period.
The retrospective studies and recent data on the allergies shows that it is a common disorder in Latin and Central America. Therefore, the market has a great potential for pollen allergic drugs market, which is also going to increase the demand for the product in the forecast period. Thus, increasing prevalence of different kind of allergies is expected to act as driver for the market in the forecast period due to which there will be expected lucrative growth in the market.
- Impact of pollen allergies on pediatric population
Pollen grains are commonly present in the atmosphere that cause various allergic diseases in North America. Pollen aeroallergens can act as opportunity for the market and propel the market in Mexico. The Impact on paediatric population depends on environmental conditions, changes in the use of soil, different pollen seasons, and annual data for allergists in terms of planning the treatment. The increase in forecasted pollen season longer than usual. The growth of the pollen market can be attributed to the increase in the tree pollen season in the country that elicits allergic reactions such as hay fever and rhinitis in the population which is anticipated to drive the market. Pollen in the atmosphere of Mexico city and its impact on the health of the paediatric population.
Hence, prevalence of pollen-induced allergic disease has been increasing with severe symptoms that can be one of the most common health issues affecting adults in Mexico. The prevalence of allergic diseases in Mexico City was 42.6%, allergic rhinitis was the most frequent. Children are the largest age group affected. The highest prevalence was found in Tlahuac country. Coexistence of allergic diseases was found in 19.9%.This is expected to be one of the factors that act as a driver for the Mexico specific pollen allergies market growth in the forecast period.
Opportunity
- Increase in the environmental pollution
Common air pollutants, such as ozone, sulphur dioxide, and nitrogen dioxide probably act more as irritants than as promoters of sensitization. These pollutants have been shown to be hazardous to adults and children with asthma. Recent studies suggest that prematurely born children are more sensitive to the respiratory effects of outdoor pollution.
Thus, pollution and allergies go hand-in-hand, worsening air and water pollution enables various heavy metals and non-metals an opportunity to come in close contact with skin and respiratory system thus causing allergies. This is increasing the demand for allergy medications.
The increasing air pollution along with water population is expected to increase the prevalence of respiratory and skin allergies, which is expected to increase the demand for the product used for allergy hence it is considered as opportunity for the market.
Restraint/Challenge
- Side effects associated with the use of drugs
Sometimes drugs have some kind of side effects or adverse effects among the population. The treatment of allergic response is a multi-drugs therapy, which has a greater chance of compatibility issue, which can cause the condition to get worse. Corticosteroids are known to lower the resistance to infection, which can make it harder to treat. It induced osteoporosis, steroids induced myopathy, and osteonecrosis are some of the disorders that are seen among those that use corticosteroids. Systemic administration of these drugs are known to increase the fasting blood glucose level, which make it vulnerable for the diabetic patients to use these therapies during allergic reaction, hence limiting the market growth.
Drowsiness, Headache, dry mouth, throat, and/or nose, stomach pain, nausea, mucus thickening, and increased appetite/weight gain are some of the side effects induced in the patient taking anti-histaminic. Among all, the drug induced diseases are mostly seen among those that use corticosteroids therapy for longer period of time. These side effects of the drug is expected to limit the use of drugs hence act as restraint for the growth of the Mexico specific pollen allergies market in the forecast period.
Post COVID-19 Impact on pollen allergies market
The COVID-19 has positively affected in the growth of the market. As there is rise in the demand for products is wide in the region. People have become more health conscious as there is prevalence of various diseases in the region which is also rising. Complications of other allergies due to aggravation are often seen and have become a problem.Hence the COVID-19 has impacted positively on this market.
Recent Developments
- In July 2021, Prestige Consumer Healthcare announced that the company has completed the previously announced acquisition of TheraTears and other over-the-counter consumer brands. This is expected to increase the company’s manufacturing capacity in the U.S. and help in revenue generation.
- In September 2021, EUROIMMUN Medizinische Labordiagnostika AG and Immunodiagnostic Systems (IDS) partnership to cooperate in the fields of research and development, production as well as distribution, and this will help to grow the business and generate revenue.
Mexico Specific Pollen Allergies Market Scope
Mexico specific pollen allergies market is categorized into five notable segments which are based on product type, diagnosis test, product, end users and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Drug Type
- Antihistamines
- Corticosteroids
- Decongestants
- Anticholinergics
- Others
Based on drug type, the market is segmented into antihistamines, corticosteroids, decongestants, anticholinergics and others.
Diagnostic Test
- In Vivo Test
- In Vitro Test
Based on diagnostic test, the market is segmented into in vivo test and in vitro test.
Product
- Instruments
- Reagents and Kits
- Others
Based on product, the market is segmented into in instruments, reagents and kits, and others
End User
- Hospitals
- Diagnostics Laboratories
- Academic and Research Institutes
- Others
Based on end user, the market is segmented into hospitals, diagnostics laboratories, academic and research institutes, and others.
Distribution Channel
- Direct Tender
- Retail Sales
Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and others.
Mexico Specific Pollen Allergies Market Regional Analysis/Insights
Mexico specific pollen allergies market is analyzed and market size insights and trends are provided by product type, diagnosis test, product, end users and distribution channel as referenced above.
The country covered in the Mexico specific pollen allergies report is Mexico.
Mexico specific pollen allergies market is expected to grow due to the rise in incidence of prevalence of allergic diseases. It shows the increase in pollen season longer than usual. The growth of the pollen market can be attributed to the increase in the tree pollen season in the country that elicits allergic reactions such as hay fever and rhinitis in the population which is anticipated to drive the market. Moreover, rising healthcare expenditure and growth of pharmaceutical market is also expected to propel the growth of the market.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Mexico Specific Pollen Allergies Market Share Analysis
Mexico specific pollen allergies market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the Mexico specific pollen allergies market.
Certains des principaux acteurs opérant sur le marché sont Siemens Healthcare GmbH, Sanofi, bioMérieux SA, GlaxoSmithKline plc., Minaris Medical America, Inc., Quest Diagnostics Incorporated, Circassia, Alcon Inc., Thermo Fisher Scientific Inc., Johnson & Johnson SA de CV, Lincoln Diagnostics, Inc., EUROIMMUN Medizinische Labordiagnostika AG, Bayer Pharmaceuticals, Prestige Consumer Healthcare Inc., CINFA LABORATORIES, Perrigo Company plc., entre autres.
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. En outre, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. La principale méthodologie de recherche utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement de l'entreprise, l'analyse des parts de marché des entreprises, les normes de mesure, le Mexique par rapport au pays et l'analyse des parts des fournisseurs. Veuillez demander un appel à l'analyste en cas de demande de renseignements supplémentaires.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MEXICO SPECIFIC POLLEN ALLERGIES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
4.3 CURRENT PATENTS THAT CAN BE USED IN ALLOPATHIC MEDICINES IN MEXICO-
4.4 INVENTION PATENT-
4.5 COUNTRY LEVEL ANALYSIS
5 REGULATIONS
5.1 MEXICO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN PREVALENCE OF ALLERGIC DISORDER
6.1.2 WIDE RANGE OF PRODUCT PORTFOLIOS OFFERED BY MAJOR PLAYER
6.1.3 IMPACT OF POLLEN ALLERGIES ON PAEDIATRICS POPULATION
6.1.4 HEALTH SECTOR REFORM AND EXPANSION OF PROGRAMMES TO BOOST HEALTHCARE SPENDING
6.2 RESTRAINTS
6.2.1 SIDE EFFECTS ASSOCIATED WITH THE USE OF DRUGS
6.2.2 INCREASE IN TREND OF USING HOME REMEDIES/PHYTOCHEMICALS
6.3 OPPORTUNITIES
6.3.1 INCREASE IN THE ENVIRONMENTAL POLLUTION
6.3.2 AWARENESS OF THE USE OF OTC PRODUCTS
6.3.3 RELAXATION OF RULES ON DIRECT-TO-CONSUMER ADVERTISING
6.4 CHALLENGES
6.4.1 INCREASE IN ABUSE POTENTIAL
6.4.2 INTELLECTUAL PROPERTY RIGHTS LAW
7 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE
7.1 OVERVIEW
7.2 ANTIHISTAMINE
7.2.1 ANTIHISTAMINE, BY DRUG TYPE
7.2.2 LEVOCETIRIZINE
7.2.3 CETIRIZINE
7.2.4 LORATIDINE
7.2.5 DIPHENHYDRAMINE
7.2.6 CHLORPHENIRAMINE
7.2.7 FEXOFENADINE
7.3 CORTICOSTEROIDS
7.3.1 FLUTICASONE PROPIONATE
7.3.2 TRIAMCINOLONE/TRIAMCINOLONE ACETONOID
7.3.3 CROMOLYN SODIUM
7.3.4 OTHERS
7.4 DECONGESTANTS
7.4.1 DECONGESTANTS, BY DRUG TYPE
7.4.2 PSEUDOEPHEDRINE
7.4.3 PHENYLEPHRINE
7.4.4 OXYMETAZOLINE
7.4.5 OTHERS
7.5 ANTICHOLINERGICS
7.5.1 ANTICHOLINERGICS, BY DRUG TYPE
7.5.2 IPRATROPIUM BROMIDE
7.5.3 OTHERS
7.6 OTHERS
8 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS
8.1 OVERVIEW
8.2 INSTRUMENTS
8.2.1 IMMUNO ASSAY ANALYZER
8.2.2 PRODUCTS, BY IMMUNOASSAY ANALYZER
8.3 RADIO IMMUNO ASSAY (RIA)
8.4 COUNTING IMMUNO ASSAY (CIA)
8.5 ENZYME LINKED IMMUNO-SORBENT ASSAYS (ELISA)
8.6 FLUOROIMMNOASSAY (FIA)
8.7 CHEMILUMINESCENCE ASSAY
8.7.1 LUMINOMETERS
8.8 REAGENTS AND KITS
8.9 OTHERS
9 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST
9.1 OVERVIEW
9.2 IN VIVO TEST
9.2.1 IN VIVO TEST, BY DIAGNOSTIC TEST
9.2.2 SKIN PRICK
9.2.2.1 SKIN PRICK, BY DIAGNOSTIC TEST
9.2.2.2 GREER PRICK
9.2.3 THE STELLAR POINT
9.2.4 PHAZET
9.2.5 BIFURCATED SMALLPOX VACCINATION TEST
9.2.6 23G INTRAVENOUS NEEDLE
9.2.7 OTHERS
9.2.8 PATCH TEST
9.2.9 INTRADERMAL TEST
9.3 IN VITRO TEST
9.3.1 IN VITRO TEST, BY DIAGNOSTIC TEST
9.3.2 SERUM SPECIFIC IGE ASSAY
9.3.3 TOTAL IGE ASSAY
9.3.4 BASOPHIL ACTIVATION TEST
10 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 DIAGNOSTICS LABORATORIES
10.4 ACADEMIC AND RESEARCH INSTITUTES
10.5 OTHERS
11 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.3.1 RETAIL SALES, BY TYPE
11.3.2 HOSPITAL PHARMACY
11.3.3 RETAIL PHARMACY
11.3.4 ONLINE PHARMACY
12 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MEXICO SPECIFIC POLLEN ALLERGIES MARKET
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 GLAXOSMITHKLINE PLC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 JOHNSON & JOHNSON SERVICES, INC
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 PERRIGO COMPANY PLC
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 SIEMENS HEALTHCARE GMBH
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 THERMO FISHER SCIENTIFIC INC.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.6 BAYER AG
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 ALCON INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BIOMÉRIEUX, SA.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.9 CINFA LABORATORIES
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 CIRCASSIA
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENTS
14.11 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 LINCOLN DIAGNOSTICS, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 MINARIS MEDICAL AMERICA, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 PRESTIGE CONSUMER HEALTHCARE INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 QUEST DIAGNOSTICS INCORPORATED
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
14.16 SANOFI
14.16.1 COMPANY SNAPSHOT
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
Liste des tableaux
TABLE 1 LEVOCETIRIZINE / MONTELUKAST- GLENMARK PHARMACEUTICALS LIMITED
TABLE 2 LEVOCETIRIZINE AND MONTELUKAST-
TABLE 3 DRUGS IN MEXICO SHOULD BE REGISTERED (SANITARY REGISTRY/HEALTH RECORD) WITH COFEPRIS BEFORE MARKETING IN MEXICO.
TABLE 4 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 5 MEXICO ANTIHISTAMINE DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 6 MEXICO ANTIHISTAMINE DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (UNITS)
TABLE 7 MEXICO CORTICOSTEROIDS DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 8 MEXICO CORTICOSTEROID DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (UNITS)
TABLE 9 MEXICO DECONGESTANTS DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 10 MEXICO DECONGESTANTS DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (UNITS)
TABLE 11 MEXICO ANTICHOLINERGIC DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 12 MEXICO ANTICHOLINERGICS DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (UNITS)
TABLE 13 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS, 2020-2029 (USD MILLION)
TABLE 14 MEXICO INSTRUMENTS IN SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS, 2020-2029 (USD MILLION)
TABLE 15 MEXICO IMMUNO ASSAY ANALYZER IN SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS, 2020-2029 (USD MILLION)
TABLE 16 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST, 2020-2029 (USD MILLION)
TABLE 17 MEXICO IN VIVO TEST IN SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST, 2020-2029 (USD MILLION)
TABLE 18 MEXICO SKIN PRICK TEST IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 19 MEXICO IN VITRO TEST IN SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST, 2020-2029 (USD MILLION)
TABLE 20 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 21 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 22 MEXICO RETAIL SALES IN SPECIFIC POLLEN ALLERGIES MARKET, BY TYPE, 2020-2029 (USD MILLION)
Liste des figures
FIGURE 1 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: SEGMENTATION
FIGURE 2 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: DATA TRIANGULATION
FIGURE 3 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: DROC ANALYSIS
FIGURE 4 MEXICO SPECIFIC POLLEN ALLERGIES MARKET : COUNTRY VS REGIONAL MARKET ANALYSIS
FIGURE 5 MEXICO SPECIFIC POLLEN ALLERGIES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: SEGMENTATION
FIGURE 11 THE HIGH PREVALENCE OF ALLERGIC RESPONSE AND INCREASING APPROVAL OF NEW PRODUCT IS EXPECTED TO DRIVE THE MEXICO SPECIFIC POLLEN ALLERGIES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 DRUG TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MEXICO SPECIFIC POLLEN ALLERGIES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MEXICO SPECIFIC POLLEN ALLERGIES MARKET
FIGURE 14 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2021
FIGURE 15 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS, 2021
FIGURE 16 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST, 2021
FIGURE 17 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY END USER, 2021
FIGURE 18 MEXICO SPECIFIC POLLEN ALLERGIES MARKET, BY DISTRIBUTION CHANNEL, 2021
FIGURE 19 MEXICO SPECIFIC POLLEN ALLERGIES MARKET: COMPANY SHARE 2021 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.